Enanta Pharmaceuticals, Inc.
Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof
Last updated:
Abstract:
The present invention provides compounds of Formula I, ##STR00001## Pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
Status:
Grant
Type:
Utility
Filling date:
25 Oct 2017
Issue date:
24 Mar 2020